Survival following the diagnosis of noninvasive bladder cancer: WHO/International Society of Urological Pathology versus WHO classification systems.

[1]  P. Daly,et al.  Survival and progression in high grade tumour subset of G2 and G3 pT1 bladder transitional cell carcinoma. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[2]  C. Marsit,et al.  Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer. , 2005, Cancer research.

[3]  S. Johansson,et al.  Urothelial carcinoma of the upper urinary tract: comparison between the WHO/ISUP 1998 consensus classification and WHO 1999 classification system. , 2005, Urology.

[4]  J. Montie.  Histologic Grading of Noninvasive Papillary Urothelial Tumors. Validation of the 1998 WHO/ISUP System by Immunophenotyping and Follow-Up. , 2005, The Journal of urology.

[5]  D. Nicol,et al.  Papillary urothelial neoplasm of low malignant potential: reliability of diagnosis and outcome , 2004, BJU international.

[6]  C. Thorns,et al.  Prognostic significance of a grading system considering tumor heterogeneity in muscle-invasive urothelial carcinoma of the urinary bladder , 2004, International Urology and Nephrology.

[7]  K. Kihara,et al.  Long‐term outcome of bladder papillary urothelial neoplasms of low malignant potential , 2003, BJU international.

[8]  M. Janssen-Heijnen,et al.  Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems , 2002, Journal of clinical pathology.

[9]  H. Samaratunga,et al.  Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression. , 2002, Urology.

[10]  A. Formiconi,et al.  Biologic Differences Between Noninvasive Papillary Urothelial Neoplasms of Low Malignant Potential and Low-Grade (Grade 1) Papillary Carcinomas of the Bladder , 2001, The American journal of surgical pathology.

[11]  M. Marberger,et al.  Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2. , 2001, The Journal of urology.

[12]  C. Busch,et al.  Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy. , 2001, The Journal of urology.

[13]  E. Jones,et al.  Comparison of the WHO/ISUP Classification and Cytokeratin 20 Expression in Predicting the Behavior of Low-Grade Papillary Urothelial Tumors , 2001, Modern Pathology.

[14]  D. Grignon,et al.  Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival. , 2000, The American journal of surgical pathology.

[15]  C. Busch,et al.  Recurrence and progression in low grade papillary urothelial tumors. , 1999, The Journal of urology.

[16]  L. Sobin,et al.  Histological Typing of Urinary Bladder Tumours , 1999, International Histological Classification of Tumours.

[17]  Lawrence D. True,et al.  The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder , 1998 .

[18]  T. Tosteson,et al.  Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population. , 1998, Environmental health perspectives.